GENOR-B(06998) spent HK$2.604 million on February 4th to repurchase 997,500 shares.
Jiawei Biotechnology (06998) announced that on February 4, 2026, they spent 2.604 million Hong Kong dollars to repurchase 997,500 shares.
GENOR-B (06998) issued an announcement on February 4, 2026, to repurchase 997,500 shares at a cost of 2.604 million Hong Kong dollars.
Related Articles

SUNAC SERVICES (01516) subscribes to 200 million yuan of fixed income financial products.

MEGA GENOMICS (06667) announces its mid-year performance for 2025, with a net profit of 27.3 million yuan.

XJ INTL HLDGS (01765) recommends increasing the authorized share capital.
SUNAC SERVICES (01516) subscribes to 200 million yuan of fixed income financial products.

MEGA GENOMICS (06667) announces its mid-year performance for 2025, with a net profit of 27.3 million yuan.

XJ INTL HLDGS (01765) recommends increasing the authorized share capital.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


